BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36534728)

  • 1. Evolutionary Characteristics and Immunologic Divergence of Lung and Brain Metastasis Lesions in NSCLC.
    Xie T; Liu Z; Li Y; Wang S; Zhai Y; Teng F; Hao X; Wang Y; Wang H; Zhang X; Wu X; Ying J; Li J; Zhang Y; Deng Y; Xing P
    Mol Cancer Res; 2023 Apr; 21(4):374-385. PubMed ID: 36534728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036).
    Wang H; Ou Q; Li D; Qin T; Bao H; Hou X; Wang K; Wang F; Deng Q; Liang J; Zheng W; Wu X; Wang X; Shao YW; Mou Y; Chen L
    Cancer; 2019 Oct; 125(20):3535-3544. PubMed ID: 31287555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases.
    Huang RSP; Harries L; Decker B; Hiemenz MC; Murugesan K; Creeden J; Tolba K; Stabile LP; Ramkissoon SH; Burns TF; Ross JS
    Oncologist; 2022 Oct; 27(10):839-848. PubMed ID: 35598205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR mutation status and its impact on survival of Chinese non-small cell lung cancer patients with brain metastases.
    Luo D; Ye X; Hu Z; Peng K; Song Y; Yin X; Zhu G; Ji Q; Peng Y
    Tumour Biol; 2014 Mar; 35(3):2437-44. PubMed ID: 24197981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity and Clinical Effect of Epidermal Growth Factor Receptor in Primary Lung and Brain Metastases of Nonsmall Cell Lung Cancer.
    Xu S; Zhu J; Zhong D; Wang W; Wen Y; Zhang L; Jiang T
    J Surg Res; 2023 Mar; 283():674-682. PubMed ID: 36459860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational Landscape and Evolutionary Pattern of Liver and Brain Metastasis in Lung Adenocarcinoma.
    Jiang T; Fang Z; Tang S; Cheng R; Li Y; Ren S; Su C; Min W; Guo X; Zhu W; Zhang H; Hou L; Pan Y; Zhou Z; Zhang J; Zhang G; Yue Z; Chen L; Zhou C
    J Thorac Oncol; 2021 Feb; 16(2):237-249. PubMed ID: 33188911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases.
    Ge M; Zhuang Y; Zhou X; Huang R; Liang X; Zhan Q
    J Neurooncol; 2017 Nov; 135(2):413-418. PubMed ID: 28780743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer.
    Tomasini P; Serdjebi C; Khobta N; Metellus P; Ouafik L; Nanni I; Greillier L; Loundou A; Fina F; Mascaux C; Barlesi F
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer.
    Eichler AF; Kahle KT; Wang DL; Joshi VA; Willers H; Engelman JA; Lynch TJ; Sequist LV
    Neuro Oncol; 2010 Nov; 12(11):1193-9. PubMed ID: 20627894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome.
    Mogenet A; Barlesi F; Besse B; Michiels S; Karimi M; Tran-Dien A; Girard N; Mazieres J; Audigier-Valette C; Locatelli-Sanchez M; Kamal M; Gestraud P; Hamza A; Jacquet A; Jimenez M; Yara S; Greillier L; Bertucci F; Planchard D; Soria JC; Bieche I; Tomasini P
    Lung Cancer; 2022 Jul; 169():31-39. PubMed ID: 35609409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world utilization of EGFR TKIs and prognostic factors for survival in EGFR-mutated non-small cell lung cancer patients with brain metastases.
    Yu X; Sheng J; Pan G; Fan Y
    Int J Cancer; 2021 Sep; 149(5):1121-1128. PubMed ID: 33970485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in the immune microenvironment of bone metastasis in driver-positive non-small cell lung cancer.
    Yang XR; Pi C; Zhang YC; Chen ZH; Zhang XC; Zhu DQ; Yang LL; Yin JC; Deng JY; Yang MY; Luo WC; Wu YL; Zhou Q
    Mol Carcinog; 2023 Jul; 62(7):1001-1008. PubMed ID: 37067398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer.
    Lee HW; Seol HJ; Choi YL; Ju HJ; Joo KM; Ko YH; Lee JI; Nam DH
    Int J Oncol; 2012 Dec; 41(6):2013-20. PubMed ID: 23076643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
    Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
    Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases.
    Wang J; Liu Z; Pang Q; Zhang T; Chen X; Er P; Wang Y; Wang P; Wang J
    BMC Cancer; 2020 Sep; 20(1):837. PubMed ID: 32883221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting EGFR mutation status by a deep learning approach in patients with non-small cell lung cancer brain metastases.
    Haim O; Abramov S; Shofty B; Fanizzi C; DiMeco F; Avisdris N; Ram Z; Artzi M; Grossman R
    J Neurooncol; 2022 Mar; 157(1):63-69. PubMed ID: 35119589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations.
    Iuchi T; Shingyoji M; Itakura M; Yokoi S; Moriya Y; Tamura H; Yoshida Y; Ashinuma H; Kawasaki K; Hasegawa Y; Sakaida T; Iizasa T
    Int J Clin Oncol; 2015 Aug; 20(4):674-9. PubMed ID: 25336382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis.
    Skakodub A; Walch H; Tringale KR; Eichholz J; Imber BS; Vasudevan HN; Li BT; Moss NS; Hei Yu KK; Mueller BA; Powell S; Razavi P; Yu HA; Reis-Filho JS; Gomez D; Schultz N; Pike LRG
    Nat Commun; 2023 Aug; 14(1):4980. PubMed ID: 37591896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiological Features of Brain Metastases from Non-small Cell Lung Cancer Harboring
    Takamori S; Toyokawa G; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Mukae N; Hirai F; Tagawa T; Oda Y; Iwaki T; Iihara K; Honda H; Maehara Y
    Anticancer Res; 2018 Jun; 38(6):3731-3734. PubMed ID: 29848735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
    Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
    Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.